Metabolically Healthy Obesity Versus Metabolic Obesity on Long-Term Major Adverse Cardiovascular Events and Mortality in Women with Suspected Ischemic Heart Disease
Hearts · 12.06.2026 · 7 (2) · 18
DOI: 10.3390/hearts7020018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hearts, online erschienen am 12.06.2026. Verfasst von Odayme Quesada und 9 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart, Lung, and Blood Institutes, National Center for Research Resources, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background
Obesity and metabolic syndrome (MS) often co-exist; however, these conditions can exist independently as metabolically healthy obesity (MHO) and as metabolic obesity (MO).
Methods
We investigated the association between metabolic status and body weight and risk of obstructive angiographic coronary artery disease (CAD), long-term major adverse cardiovascular events (MACEs), and all-cause mortality in women with signs/symptoms of ischemic heart disease (IHD) enrolled in the original cohort of the Women’s Ischemia Syndrome Evaluation (WISE) study (1997–2001) followed for mortality for a median of 8.6 years (range: 0–11.3 years). Normal weight (NW) was defined as a body mass index (BMI) < 25 kg/m2, overweight (OW) was defined as a BMI of 25–29 kg/m2, obesity (O) was defined as ≥30 kg/m2. MS was defined according to the NCEP ATP III Harmonized definition, metabolically healthy (MHO) was defined as obesity in the absence of MS, and MO was defined as MS in NW individuals.
Results
503 women were evaluated including 20.7% MH-NW, 14.7% MH-OW, 8.5% MHO, 6.2% MO, 21.9% MS-OW, 28.0% MS-O. Compared to MH-NW (reference), MHO was associated with a lower risk of MACEs (aHR 0.50; 95% CI 0.29, 0.85, p = 0.011) and mortality (aHR 0.50; 95% CI 0.27, 0.95, p = 0.035). MO was associated with higher odds of obstructive CAD (aOR 2.10; 95% CI 1.33, 3.33, p = 0.002) and a higher risk of MACEs (aHR 1.67, 95% CI 1.07, 2.59, p = 0.023).
Conclusions
In women with suspected IHD, compared with MH-NW, MHO was associated with a lower risk of MACEs and mortality, whereas MO had higher odds of obstructive CAD and a greater MACE risk. These findings challenge simplistic BMI-based risk paradigms and emphasize the benefits of using metabolic status assessment over weight alone.
Förderung
- National Heart, Lung, and Blood Institutes
- National Center for Research Resources
- National Center for Advancing Translational Sciences
- Department of Defense
- Gustavus and Louis Pfeiffer Research Foundation
- The Ladies Hospital Aid Society of Western Pennsylvania
- Cedars-Sinai Medical Center
- QMED, Inc.
Zitieren
APA
Quesada, O., Pico, M., Lauzon, M., Wei, J., Suppogu, N., Shaw, L. J., Bittner, V., Reis, S. E., Pepine, C. J., & Merz, C. N. B. (2026). Metabolically Healthy Obesity Versus Metabolic Obesity on Long-Term Major Adverse Cardiovascular Events and Mortality in Women with Suspected Ischemic Heart Disease. Hearts, 7(2), 18. https://doi.org/10.3390/hearts7020018
Vancouver
Quesada O, Pico M, Lauzon M, Wei J, Suppogu N, Shaw LJ, et al. Metabolically Healthy Obesity Versus Metabolic Obesity on Long-Term Major Adverse Cardiovascular Events and Mortality in Women with Suspected Ischemic Heart Disease. Hearts. 2026;7(2):18. doi:10.3390/hearts7020018
BibTeX
@article{Quesada2026,
author = {Quesada, Odayme and Pico, Madison and Lauzon, Marie and Wei, Janet and Suppogu, Nissi and Shaw, Leslee J. and Bittner, Vera and Reis, Steven E. and Pepine, Carl J. and Merz, C. Noel Bairey},
title = {Metabolically Healthy Obesity Versus Metabolic Obesity on Long-Term Major Adverse Cardiovascular Events and Mortality in Women with Suspected Ischemic Heart Disease},
journal = {Hearts},
year = {2026},
volume = {7},
number = {2},
pages = {18},
doi = {10.3390/hearts7020018}
}
EUVIMED